136 related articles for article (PubMed ID: 37089905)
21. A robust approach to establish tolerance limits for the gamma passing rate-based patient-specific quality assurance using the heuristic control charts.
Xiao Q; Bai L; Li G; Zhang X; Li Z; Duan L; Peng R; Zhong R; Wang Q; Wang X; Bai S
Med Phys; 2022 Feb; 49(2):1312-1330. PubMed ID: 34778963
[TBL] [Abstract][Full Text] [Related]
22. Effects of changing modulation and pitch parameters on tomotherapy delivery quality assurance plans.
Binny D; Lancaster CM; Harris S; Sylvander SR
J Appl Clin Med Phys; 2015 Sep; 16(5):87–105. PubMed ID: 26699293
[TBL] [Abstract][Full Text] [Related]
23. Fluence-weighted average subfield size in helical TomoTherapy.
Howitz S; Wiezorek T; Wittig A; Vorwerk H; Zink K
Z Med Phys; 2019 Dec; 29(4):337-348. PubMed ID: 31056376
[TBL] [Abstract][Full Text] [Related]
24. On the complexity of helical tomotherapy treatment plans.
Santos T; Ventura T; Mateus J; Capela M; Lopes MDC
J Appl Clin Med Phys; 2020 Jul; 21(7):107-118. PubMed ID: 32363800
[TBL] [Abstract][Full Text] [Related]
25. A virtual source model for Monte Carlo simulation of helical tomotherapy.
Yuan J; Rong Y; Chen Q
J Appl Clin Med Phys; 2015 Jan; 16(1):4992. PubMed ID: 25679157
[TBL] [Abstract][Full Text] [Related]
26. Independent verification of transferred delivery sinogram between two dosimetrically matched helical tomotherapy machines: a protocol for patient-specific quality assurance.
Yaddanapudi S; Oddiraju S; Rodriguez V; Green OL; Low DA; Rangaraj D; Mutic S; Goddu SM
Phys Med Biol; 2012 Sep; 57(17):5617-31. PubMed ID: 22892686
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the dataset quality in gamma passing rate predictions using machine learning methods.
Quintero P; Benoit D; Cheng Y; Moore C; Beavis A
Br J Radiol; 2023 Jul; 96(1147):20220302. PubMed ID: 37129359
[TBL] [Abstract][Full Text] [Related]
28. Clinical implementation of Dosimetry Check™ for TomoTherapy
Chung E; Kwon D; Park T; Kang H; Chung Y
J Appl Clin Med Phys; 2018 Nov; 19(6):193-199. PubMed ID: 30354001
[TBL] [Abstract][Full Text] [Related]
29. SEAFARER - A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practice.
Lehmann J; Hussein M; Barry MA; Siva S; Moore A; Chu M; Díez P; Eaton DJ; Harwood J; Lonski P; Claridge Mackonis E; Meehan C; Patel R; Ray X; Shaw M; Shepherd J; Smyth G; Standen TS; Subramanian B; Greer PB; Clark CH
Radiother Oncol; 2022 Jun; 171():121-128. PubMed ID: 35461949
[TBL] [Abstract][Full Text] [Related]
30. Beam commissioning and measurements validating the beam model in a new TPS that converts helical tomotherapy plans to step-and-shoot IMRT plans.
Petersson K; Ceberg C; Engström P; Knöös T
Med Phys; 2011 Jan; 38(1):40-6. PubMed ID: 21361173
[TBL] [Abstract][Full Text] [Related]
31. Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy.
Kron T; Grigorov G; Yu E; Yartsev S; Chen JZ; Wong E; Rodrigues G; Trenka K; Coad T; Bauman G; Van Dyk J
Phys Med Biol; 2004 Aug; 49(16):3675-90. PubMed ID: 15446797
[TBL] [Abstract][Full Text] [Related]
32. Independent calculation of dose distributions for helical tomotherapy using a conventional treatment planning system.
Klüter S; Schubert K; Lissner S; Sterzing F; Oetzel D; Debus J; Schlegel W; Oelfke U; Nill S
Med Phys; 2014 Aug; 41(8):081709. PubMed ID: 25086519
[TBL] [Abstract][Full Text] [Related]
33. Implementation of TG-218 for patient-specific quality assurance tolerance and action limits determination: Gamma passing rate evaluation using 3DVH software.
Stasinou D; Patatoukas G; Kollaros N; Diamantopoulos S; Kypraiou E; Kougioumtzopoulou A; Kouloulias V; Efstathopoulos E; Platoni K
Med Phys; 2022 Jul; 49(7):4322-4334. PubMed ID: 35560362
[TBL] [Abstract][Full Text] [Related]
34. Deep learning for patient-specific quality assurance: Identifying errors in radiotherapy delivery by radiomic analysis of gamma images with convolutional neural networks.
Nyflot MJ; Thammasorn P; Wootton LS; Ford EC; Chaovalitwongse WA
Med Phys; 2019 Feb; 46(2):456-464. PubMed ID: 30548601
[TBL] [Abstract][Full Text] [Related]
35. Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors.
Soisson ET; Tomé WA; Richards GM; Mehta MP
Radiother Oncol; 2006 Mar; 78(3):313-21. PubMed ID: 16490269
[TBL] [Abstract][Full Text] [Related]
36. Experimental Validation of Monte Carlo Simulations Based on a Virtual Source Model for TomoTherapy in a RANDO Phantom.
Yuan J; Zheng Y; Wessels B; Lo SS; Ellis R; Machtay M; Yao M
Technol Cancer Res Treat; 2016 Dec; 15(6):796-804. PubMed ID: 26376697
[TBL] [Abstract][Full Text] [Related]
37. Matched linac stereotactic radiotherapy: An assessment of delivery similarity and distributive patient-specific quality assurance feasibility.
Goodall SK; Dunn L; Dunning J; Muñoz L; Rowshanfarzad P; Ebert MA
J Appl Clin Med Phys; 2022 Nov; 23(11):e13652. PubMed ID: 35570398
[TBL] [Abstract][Full Text] [Related]
38. Multi-institution validation of a new high spatial resolution diode array for SRS and SBRT plan pretreatment quality assurance.
Rose MS; Tirpak L; Van Casteren K; Zack J; Simon T; Schoenfeld A; Simon W
Med Phys; 2020 Jul; 47(7):3153-3164. PubMed ID: 32215929
[TBL] [Abstract][Full Text] [Related]
39. Comparison of complexity metrics for multi-institutional evaluations of treatment plans in radiotherapy.
Hernandez V; Saez J; Pasler M; Jurado-Bruggeman D; Jornet N
Phys Imaging Radiat Oncol; 2018 Jan; 5():37-43. PubMed ID: 33458367
[TBL] [Abstract][Full Text] [Related]
40. Statistical process control and process capability analysis for non-normal volumetric modulated arc therapy patient-specific quality assurance processes.
Xiao Q; Bai S; Li G; Yang K; Bai L; Li Z; Chen L; Xian L; Hu Z; Zhong R
Med Phys; 2020 Oct; 47(10):4694-4702. PubMed ID: 32677053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
